Allianz Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Allianz Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-79,159	Closed	-$1.87M	–	2731
2016 Q3	$1.87M	Buy	79,159 +31,305	+65%	+$841K	﹤0.01%	2008
2016 Q2	$1.38M	Sell	47,854 -175,987	-79%	-$5.74M	﹤0.01%	2067
2016 Q1	$7.17M	Buy	223,841 +33,358	+18%	+$1.17M	0.01%	1296
2015 Q4	$8.17M	Sell	190,483 -36,320	-16%	-$1.45M	0.01%	1146
2015 Q3	$7.99M	Buy	226,803 +22,815	+11%	+$1.03M	0.01%	1076
2015 Q2	$9.37M	Buy	203,988 +49,995	+32%	+$2.37M	0.01%	1124
2015 Q1	$7.22M	Buy	153,993 +116,243	+308%	+$4.63M	0.01%	1086
2014 Q4	$1.2M	Buy	+37,750	New	+$1.1M	﹤0.01%	1768

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management's IPXL Position: Q4 2016 in Review

Allianz Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 79,159 shares — an estimated $1.87M sold.

Allianz Asset Management first reported a position in IPXL in Q4 2014 and held it in 8 quarters. The position peaked at $9.37M in Q2 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

Allianz Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
Allianz Asset Management sold 79,159 Impax Laboratories, Inc. shares in Q4 2016, an estimated $1.87M.
Allianz Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 8 quarters.
Allianz Asset Management's Impax Laboratories, Inc. position peaked at $9.37M in Q2 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.